Morgan Stanley Smith Barney files TRDA Form 144; 15,000 shares sold (TRDA)
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting the sale of 15,000 shares of Common Stock on 05/04/2026 following the exercise of stock options for cash. The filing also lists multiple 10b5-1 sales by Nathan Dowden in March 2026 with per-trade share counts and proceeds.
Positive
- None.
Negative
- None.
Key Figures
Shares sold (May 4, 2026): 15,000 shares
Sale proceeds (03/03/2026): $165,036.34
Sale proceeds (03/02/2026): $84,205.01
+2 more
5 metrics
Shares sold (May 4, 2026)
15,000 shares
Exercise of stock options on 05/04/2026
Sale proceeds (03/03/2026)
$165,036.34
10b5-1 sale of 14,038 shares on 03/03/2026
Sale proceeds (03/02/2026)
$84,205.01
Sale of 7,223 shares on 03/02/2026
Sale proceeds (03/10/2026)
$155,188.15
10b5-1 sale of 11,894 shares on 03/10/2026
Sale proceeds (03/09/2026)
$40,582.78
10b5-1 sale of 3,116 shares on 03/09/2026
Key Terms
Form 144, 10b5-1, Exercise of Stock Options
3 terms
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"10b5-1 Sales for NATHAN DOWDEN One Design Center Place"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 05/04/2026 | Exercise of Stock Options"
FAQ
What did TRDA report in the Form 144 filing?
The filing reports a sale of 15,000 shares on 05/04/2026 following an exercise of stock options. It also records several 10b5-1 sales by Nathan Dowden in March 2026 with individual share counts and proceeds.
Who executed the March 2026 10b5-1 sales listed in TRDA's filing?
The March 2026 10b5-1 sales are attributed to Nathan Dowden. The filing lists trades on 03/02, 03/03, 03/09, and 03/10/2026 with specific share counts and dollar proceeds for each trade.
Does the Form 144 specify who received the cash from the May 4, 2026 transaction?
The filing indicates the exercise was processed by the Issuer and settled for cash on 05/04/2026. It does not allocate proceeds beyond showing the transaction method and recipient as the issuer.